Search
Close this search box.

The Price and Value of Orphan Drugs

How do you put a price tag on a drug that offers life-altering results – but for a small group of patients? The question is becoming increasingly relevant with the rise of innovative, targeted medicine.

Drugs, Data & Opioid Policies

America’s drug abuse crisis has reached epic proportions, a recent report from the Centers for Disease Control and Prevention confirms. Drug-related deaths in 2016 alone spiked by 22 percent.

Why Patients with Skin Conditions Can’t Get Treated

Tens of millions of people across the United States are affected by skin conditions, but not all of them can access the doctors and medications they need. So explains a new white paper from the Derma Care Access Network, an advocacy group that encourages informed policy on access to dermatological care.

Best of Summer 2017

Vacation season?  Perhaps.  But summer hasn’t slowed the Institute for Patient Access’ steady stream of physician-led insight on policy issues that matter to patients and their health care providers.